Clinical Trials Directory

Trials / Completed

CompletedNCT04643522

Semen Parameters and COVID-19 in Infertile Men

Does COVID-19 Worsen the Semen Parameters? Early Results of a Tertiary Health Center

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Ankara City Hospital Bilkent · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Coronavirus Disease-19 (COVID-19) is a global pandemics which affects many organs and systems with a range of morbidities and high mortality rates. There are a number of studies revealed that COVID-19 may affect the testes and male genital tract which may in turn disrupt the gonadal functions.The current study aimed to evaluate the effect of COVID-19 on semen parameters and sex-related hormone levels.

Detailed description

In this current study, the investigators aimed to elucidate the alteration in semen parameters of the infertile male patients who had been infected with SARS-CoV-2, through the comparison of the spermiogram results which were reported before and after the diagnosis of COVID-19. The investigators also aimed to evaluate the impact of COVID-19 on the sex-related hormone levels as follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone (T). The current study is conducted in Ankara City Hospital, the highest capacity tertiary health care center of the capital town of Turkey. The study included 21 patients who applied to Ankara City Hospital, Andrology Clinic for male infertility up to 05 October, 2020 and have had the semen analyses reported before and after the clinically confirmed diagnosis of COVID-19 through reverse transcriptase PCR. Besides the semen analyses, 8 of these 21 patients have also the had the reported levels of T, FSH and LH which were also analyzed.

Conditions

Interventions

TypeNameDescription
OTHERClinical assessmentComparison of semen analysis results and sex-related hormone levels between the dependent groups which were defined as before COVID-19 and after COVID-19 (the data of the same patient group were compared as before and after the diagnosis of COVID-19).

Timeline

Start date
2020-01-07
Primary completion
2020-10-05
Completion
2020-10-10
First posted
2020-11-25
Last updated
2020-11-30

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04643522. Inclusion in this directory is not an endorsement.